Essential role of nitric oxide in acute ischemic preconditioning

S-Nitros(yl)ation versus sGC/cGMP/PKG signaling?

Junhui Sun, Angel M. Aponte, Mark Kohr, Guang Tong, Charles Jr Steenbergen, Elizabeth Murphy

Research output: Contribution to journalArticle

Abstract

Nitric oxide (NO) plays an important role in acute ischemic preconditioning (IPC). In addition to activating soluble guanylyl cyclase (sGC)/cyclic guanosine monophosphate (cGMP)/protein kinase G (PKG) signaling pathways, NO-mediated protein S-nitros(yl)ation (SNO) has been recently shown to play an essential role in cardioprotection against ischemia-reperfusion (I/R) injury. In our previous studies, we have shown that IPC-induced cardioprotection could be blocked by treatment with either N-nitro-L-arginine methyl ester (L-NAME, a constitutive NO synthase inhibitor) or ascorbate (a reducing agent to decompose SNO). To clarify NO-mediated sGC/cGMP/PKG-dependent or -independent (i.e., SNO) signaling involved in IPC-induced cardioprotection, mouse hearts were Langendorff-perfused in the dark to prevent SNO decomposition by light exposure. Treatment with 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ, a highly selective inhibitor of sGC) or KT5823 (a potent and selective inhibitor of PKG) did not abolish IPC-induced acute protection, suggesting that the sGC/cGMP/PKG signaling pathway does not play an important role in NO-mediated cardioprotective signaling during acute IPC. In addition, treatment with ODQ in IPC hearts provided an additional protective effect on functional recovery, in parallel with a higher SNO level in these ODQ+IPC hearts. In conclusion, these results suggest that the protective effect of NO is not related primarily to activation of the sGC/cGMP/PKG signaling pathway, but rather through SNO signaling in IPC-induced acute cardioprotection.

Original languageEnglish (US)
Pages (from-to)105-112
Number of pages8
JournalFree Radical Biology and Medicine
Volume54
DOIs
StatePublished - Jan 2013

Fingerprint

Guanylate Kinases
Cyclic GMP-Dependent Protein Kinases
Ischemic Preconditioning
Guanylate Cyclase
Cyclic GMP
Nitric Oxide
Arginine
Protein S
NG-Nitroarginine Methyl Ester
Reducing Agents
Nitric Oxide Synthase
Soluble Guanylyl Cyclase
Esters
Reperfusion Injury
Chemical activation
Decomposition
Recovery
Therapeutics
Light

Keywords

  • Ischemic preconditioning
  • Nitric oxide
  • Protein S-nitros(yl)ation
  • sGC/cGMP/PKG

ASJC Scopus subject areas

  • Biochemistry
  • Physiology (medical)

Cite this

Essential role of nitric oxide in acute ischemic preconditioning : S-Nitros(yl)ation versus sGC/cGMP/PKG signaling? / Sun, Junhui; Aponte, Angel M.; Kohr, Mark; Tong, Guang; Steenbergen, Charles Jr; Murphy, Elizabeth.

In: Free Radical Biology and Medicine, Vol. 54, 01.2013, p. 105-112.

Research output: Contribution to journalArticle

@article{c50e0f52abbd4ff899a52e4f30bed6b7,
title = "Essential role of nitric oxide in acute ischemic preconditioning: S-Nitros(yl)ation versus sGC/cGMP/PKG signaling?",
abstract = "Nitric oxide (NO) plays an important role in acute ischemic preconditioning (IPC). In addition to activating soluble guanylyl cyclase (sGC)/cyclic guanosine monophosphate (cGMP)/protein kinase G (PKG) signaling pathways, NO-mediated protein S-nitros(yl)ation (SNO) has been recently shown to play an essential role in cardioprotection against ischemia-reperfusion (I/R) injury. In our previous studies, we have shown that IPC-induced cardioprotection could be blocked by treatment with either N-nitro-L-arginine methyl ester (L-NAME, a constitutive NO synthase inhibitor) or ascorbate (a reducing agent to decompose SNO). To clarify NO-mediated sGC/cGMP/PKG-dependent or -independent (i.e., SNO) signaling involved in IPC-induced cardioprotection, mouse hearts were Langendorff-perfused in the dark to prevent SNO decomposition by light exposure. Treatment with 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ, a highly selective inhibitor of sGC) or KT5823 (a potent and selective inhibitor of PKG) did not abolish IPC-induced acute protection, suggesting that the sGC/cGMP/PKG signaling pathway does not play an important role in NO-mediated cardioprotective signaling during acute IPC. In addition, treatment with ODQ in IPC hearts provided an additional protective effect on functional recovery, in parallel with a higher SNO level in these ODQ+IPC hearts. In conclusion, these results suggest that the protective effect of NO is not related primarily to activation of the sGC/cGMP/PKG signaling pathway, but rather through SNO signaling in IPC-induced acute cardioprotection.",
keywords = "Ischemic preconditioning, Nitric oxide, Protein S-nitros(yl)ation, sGC/cGMP/PKG",
author = "Junhui Sun and Aponte, {Angel M.} and Mark Kohr and Guang Tong and Steenbergen, {Charles Jr} and Elizabeth Murphy",
year = "2013",
month = "1",
doi = "10.1016/j.freeradbiomed.2012.09.005",
language = "English (US)",
volume = "54",
pages = "105--112",
journal = "Free Radical Biology and Medicine",
issn = "0891-5849",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Essential role of nitric oxide in acute ischemic preconditioning

T2 - S-Nitros(yl)ation versus sGC/cGMP/PKG signaling?

AU - Sun, Junhui

AU - Aponte, Angel M.

AU - Kohr, Mark

AU - Tong, Guang

AU - Steenbergen, Charles Jr

AU - Murphy, Elizabeth

PY - 2013/1

Y1 - 2013/1

N2 - Nitric oxide (NO) plays an important role in acute ischemic preconditioning (IPC). In addition to activating soluble guanylyl cyclase (sGC)/cyclic guanosine monophosphate (cGMP)/protein kinase G (PKG) signaling pathways, NO-mediated protein S-nitros(yl)ation (SNO) has been recently shown to play an essential role in cardioprotection against ischemia-reperfusion (I/R) injury. In our previous studies, we have shown that IPC-induced cardioprotection could be blocked by treatment with either N-nitro-L-arginine methyl ester (L-NAME, a constitutive NO synthase inhibitor) or ascorbate (a reducing agent to decompose SNO). To clarify NO-mediated sGC/cGMP/PKG-dependent or -independent (i.e., SNO) signaling involved in IPC-induced cardioprotection, mouse hearts were Langendorff-perfused in the dark to prevent SNO decomposition by light exposure. Treatment with 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ, a highly selective inhibitor of sGC) or KT5823 (a potent and selective inhibitor of PKG) did not abolish IPC-induced acute protection, suggesting that the sGC/cGMP/PKG signaling pathway does not play an important role in NO-mediated cardioprotective signaling during acute IPC. In addition, treatment with ODQ in IPC hearts provided an additional protective effect on functional recovery, in parallel with a higher SNO level in these ODQ+IPC hearts. In conclusion, these results suggest that the protective effect of NO is not related primarily to activation of the sGC/cGMP/PKG signaling pathway, but rather through SNO signaling in IPC-induced acute cardioprotection.

AB - Nitric oxide (NO) plays an important role in acute ischemic preconditioning (IPC). In addition to activating soluble guanylyl cyclase (sGC)/cyclic guanosine monophosphate (cGMP)/protein kinase G (PKG) signaling pathways, NO-mediated protein S-nitros(yl)ation (SNO) has been recently shown to play an essential role in cardioprotection against ischemia-reperfusion (I/R) injury. In our previous studies, we have shown that IPC-induced cardioprotection could be blocked by treatment with either N-nitro-L-arginine methyl ester (L-NAME, a constitutive NO synthase inhibitor) or ascorbate (a reducing agent to decompose SNO). To clarify NO-mediated sGC/cGMP/PKG-dependent or -independent (i.e., SNO) signaling involved in IPC-induced cardioprotection, mouse hearts were Langendorff-perfused in the dark to prevent SNO decomposition by light exposure. Treatment with 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ, a highly selective inhibitor of sGC) or KT5823 (a potent and selective inhibitor of PKG) did not abolish IPC-induced acute protection, suggesting that the sGC/cGMP/PKG signaling pathway does not play an important role in NO-mediated cardioprotective signaling during acute IPC. In addition, treatment with ODQ in IPC hearts provided an additional protective effect on functional recovery, in parallel with a higher SNO level in these ODQ+IPC hearts. In conclusion, these results suggest that the protective effect of NO is not related primarily to activation of the sGC/cGMP/PKG signaling pathway, but rather through SNO signaling in IPC-induced acute cardioprotection.

KW - Ischemic preconditioning

KW - Nitric oxide

KW - Protein S-nitros(yl)ation

KW - sGC/cGMP/PKG

UR - http://www.scopus.com/inward/record.url?scp=84871926566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871926566&partnerID=8YFLogxK

U2 - 10.1016/j.freeradbiomed.2012.09.005

DO - 10.1016/j.freeradbiomed.2012.09.005

M3 - Article

VL - 54

SP - 105

EP - 112

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

SN - 0891-5849

ER -